AI assistant
INSMED Inc — Director's Dealing 2021
May 14, 2021
30150_dirs_2021-05-14_1b26763c-7d9f-4d1d-84eb-dd9c1725c307.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: INSMED Inc (INSM)
CIK: 0001104506
Period of Report: 2021-05-12
Reporting Person: Bonstein Sara (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-05-12 | Common Stock | A | 14172 | — | Acquired | 23355 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-05-12 | Stock Option (right to buy) | $26.46 | A | 68640 | Acquired | 2031-05-12 | Common Stock (68640) | Direct |
Footnotes
F1: Represents Restricted Stock Units, each representing a contingent right to receive one share of Common Stock, granted pursuant to the Company's 2019 Incentive Plan. The Restricted Stock Units vest and become available as follows: twenty five (25%) percent on each anniversary of the date of grant through the fourth anniversary date of the grant.
F2: Each Restricted Stock Unit was received as a grant on May 12, 2021, for no consideration.
F3: Stock options granted under the Company's 2019 Incentive Plan. The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.